HEC has opened applications for fully funded PhD scholarships for Pakistani students under the US-Pakistan Knowledge Corridor Project. Funding covers tuition, stipend and health insurance for top 50 ...
After dropping headline-grabbing phase 3 data for its pancreatic cancer candidate daraxonrasib last week, Revolution Medicines is not resting on its laurels. The Bay Area biotech has spent several ...
Islamabad: The Higher Education Commission (HEC) is preparing to introduce a blockchain-powered digital degree attestation system that will allow students to verify their academic credentials online ...
Hydrological data are typically sequential and often correspond to large datasets, and not all application programs allow their retrieval, storage, and manipulation. This technical article aims to ...
PARIS — RAS Luxury Skincare, the Indian farm-to-face brand, closed a 65 Crores, or $7.5 million, Series B funding round led by Dabur Ventures. Dabur Ventures is the venture arm of the largest ...
Ras Kass returns with “Leopard Eats Face,” a feature-heavy Hip-Hop statement blending everything he is in one great project. AllHipHop caught up with a certified lyricist as he gears up for his latest ...
Company plans to continue rapidly advancing clinical development program for VS-7375, a highly selective, oral KRAS G12D (ON/OFF) inhibitor with best-in-class potential, in several advanced KRAS G12D ...
A comprehensive, modular Python automation system for HEC-RAS flood analysis workflows. This professional-grade tool demonstrates advanced hydraulic modeling capabilities, Python integration, and ...
Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...
Two 137 m replenishment ships for the Portuguese Navy, ordered from STM, shown in a concept graphic released in September 2025. (STM) Kongsberg Maritime has signed a contract with Turkish shipbuilder ...
Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.
Patients who received GLP-1 RAs had significantly higher rates of diabetes, hyperlipemia, and chronic obstructive pulmonary disease than those who underwent surgery. After 3 years, patients who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results